Search results

ANSTO researchers are investigating nuclear propulsion systems for applications on the sea and in space.

The Australian led regional cancer care project in medical physics held its first regional training course in Malaysia to progress Rays of Hope.

Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial

ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.

ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.

ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

Accurate ‘fingerprinting’ tool to verify source of origin is in development with collaborators from academia and industry.

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

Meeting of minds about potential next-generation cancer treatment for Australians

On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.

State- of-the-art microdosimeters used in research

Molten Salt Reactors (MSRs) are nuclear reactors that use a fluid fuel in the form of very hot fluoride or chloride salt rather than the solid fuel used in most reactors. Since the fuel salt is liquid, it can be both the fuel to produce heat and the coolant to transport the heat to a power plant.

The Japanese experience with leading-edge radiation treatment for cancer shows tremndous success

With enhanced submicron spatial resolution, speed and contrast, the Micro-Computed Tomography beamline opens a window on the micron-scale 3D structure of a wide range of samples relevant to many areas of science including life sciences, materials engineering, anthropology, palaeontology and geology. MCT will be able to undertake high-speed and high-throughput studies, as well as provide a range of phase-contrast imaging modalities.

Following a decade of imaging to support research and clinical trials at ANSTO and the University of Sydney’s Brain and Mind Centre at Camperdown, two PET scanners have been transferred to the University of Wollongong.

ANSTO is a partner on the National Space Qualification Network (NSQN) led by the Australian National University (ANU) that will transform Australia into a world-leading space centre by enhancing facilities to test payloads, components, and hardware prior to their use in harsh environments of space.

The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.